专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5451688A Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses 失效
标题翻译：六氢萘酯衍生物，其制备及其治疗用途
公开(公告)号：US5451688A
公开(公告)日：1995-09-19
申请号：US174661
申请日：1993-12-28
申请人： Hiroshi Kogen , Sadao Ishihara , Teiichiro Koga , Eiichi Kitazawa , Nobufusa Serizawa , Kiyoshi Hamano
发明人： Hiroshi Kogen , Sadao Ishihara , Teiichiro Koga , Eiichi Kitazawa , Nobufusa Serizawa , Kiyoshi Hamano
IPC分类号： A61K31/22 , A61K31/35 , A61K31/365 , A61K31/366 , A61P3/06 , C07C69/03 , C07C69/24 , C07C69/33 , C07C69/67 , C07C69/675 , C07C69/732 , C07C69/734 , C07D309/30 , C12N9/02 , C12P7/62 , C12P17/06 , C12R1/01 , C12R1/465 , C12R1/785 , C07C69/74
CPC分类号： C07C69/33 , C07C69/675 , C07C69/732 , C07D309/30 , C12N9/0093 , C12P17/06 , C12P7/62 , Y02P20/55
摘要： Compounds of formula (I): ##STR1## [wherein R.sup.1 represents a group of formula (II) or (III): ##STR2## R.sup.2 is alkyl, alkenyl or alkynyl; R.sup.3 and R.sup.4 are each hydrogen, alkyl, alkenyl or alkynyl; R.sup.5 is hydrogen or a carboxy-protecting group; R.sup.a is hydrogen or a group of formula and --OR.sup.6 ; R.sup.6, R.sup.6a and R.sup.6b are each hydrogen, a hydroxy-protecting group, alkyl, alkanesulfonyl, halogenated alkanesulfonyl or arylsulfonyl] and their salts and esters have the ability to inhibit the synthesis of cholesterol, and can thus be used for the treatment and prophylaxis of hypercholesterolemia and of various cardiac disorders.
摘要翻译：式（I）化合物：其中R 1表示式（II）或（III）的基团：烯基或炔基; R3和R4各自为氢，烷基，烯基或炔基; R5是氢或羧基保护基; R a是氢或式-OR 6基团; R6，R6a和R6b各自为氢，羟基保护基，烷基，烷基磺酰基，卤代烷磺酰基或芳基磺酰基），其盐和酯具有抑制胆固醇合成的能力，因此可用于治疗和预防高胆固醇血症和各种心脏疾病。

2. 发明授权

US5827855A Hexahydronaphthalene ester derivatives their preparation and their therapeutic uses 失效
标题翻译：六氢萘酯衍生物的制备及其治疗用途
公开(公告)号：US5827855A
公开(公告)日：1998-10-27
申请号：US579840
申请日：1995-12-28
申请人： Hiroshi Kogen , Sadao Ishihara , Teiichiro Koga , Eiichi Kitazawa , Nobufusa Serizawa , Kiyoshi Hamano
发明人： Hiroshi Kogen , Sadao Ishihara , Teiichiro Koga , Eiichi Kitazawa , Nobufusa Serizawa , Kiyoshi Hamano
IPC分类号： A61K31/22 , A61K31/35 , A61K31/365 , A61K31/366 , A61P3/06 , C07C69/03 , C07C69/24 , C07C69/33 , C07C69/67 , C07C69/675 , C07C69/732 , C07C69/734 , C07D309/30 , C12N9/02 , C12P7/62 , C12P17/06 , C12R1/01 , C12R1/465 , C12R1/785 , A01N43/42 , C07C67/74
CPC分类号： C07C69/33 , C07C69/675 , C07C69/732 , C07D309/30 , C12N9/0093 , C12P17/06 , C12P7/62 , Y02P20/55
摘要： Compounds of formula (I): ##STR1## wherein R.sup.1 represents a group of formula (II) or (III): ##STR2## R.sup.2 is alkyl, alkenyl or alkynyl; R.sup.3 and R.sup.4 are each hydrogen, alkyl, alkenyl or alkynyl; R.sup.5 is hydrogen or a carboxy-protecting group; R.sup.a is a group of formula --OR.sup.6 ; R.sup.6 is hydrogen; R.sup.6a and R.sup.6b are each hydrogen, a hydroxy-protecting group, alkyl, alkanesulfonyl, halogenated alkanesulfonyl or arysulfonyl, and their salts and esters. Such compounds inhibit the synthesis of cholesterol, and can be used for the treatment and prophylaxis of hypercholesterolemia and of various cardiac disorders.
摘要翻译：（I）的化合物：其中R 1表示式（II）或（III）的基团：其中R 2是烷基，烯基或炔基; R3和R4各自为氢，烷基，烯基或炔基; R5是氢或羧基保护基; Ra是式-OR6的一组; R6是氢; R6a和R6b各自为氢，羟基保护基，烷基，烷磺酰基，卤代烷磺酰基或芳磺酰基，以及它们的盐和酯。这些化合物抑制胆固醇的合成，并可用于治疗和预防高胆固醇血症和各种心脏疾病。

3. 发明授权

US5153124A Hydroxyl-ML-236B derivatives, their preparation and use 失效
标题翻译：羟基-LM-236B衍生物，其制备和使用
公开(公告)号：US5153124A
公开(公告)日：1992-10-06
申请号：US393001
申请日：1989-08-11
申请人： Kouhei Furuya , Takao Okazaki , Yoshio Tsujita , Seigo Iwado , Kiyoshi Hamano , Masao Kuroda , Jun Yoshikawa , Toshiaki Iwai , Kunio Nakano
发明人： Kouhei Furuya , Takao Okazaki , Yoshio Tsujita , Seigo Iwado , Kiyoshi Hamano , Masao Kuroda , Jun Yoshikawa , Toshiaki Iwai , Kunio Nakano
IPC分类号： A61K31/225 , C07C67/31 , C07C69/675 , C07D309/10 , C07D309/30 , C12P7/62 , C12P17/06
CPC分类号： C12R1/645 , C07D309/10 , C12P17/06 , C12P7/62 , C12R1/365
摘要： Derivatives of ML-236B carboxylic acid, its salts and esters and corresponding lactone have a hydroxy group at the 3"-position and optionally also at the 6'-position. These derivatives may be prepared by the enzymatic hydroxylation of a corresponding ML-236B compound employing an enzyme produced by a microorganism of the genus Streptomyces or Amycolata, especially Streptomyces sp. SANK 62285, Streptomyces sp. SANK 62385, Streptomyces sp. SANK 62485, Streptomyces sp. SANK 62585, Amycolata autotrophica SANK 62781, Amycolata autotrophica subsp. canberrica SANK 62882 or Amycolata autotrophica subsp. amethystina SANK 62981. These derivatives have the ability to inhibit cholesterol biosynthesis.
摘要翻译： ML-236B羧酸的衍生物，其盐和酯和相应的内酯在3“位和任选也在6'位具有羟基。这些衍生物可以通过使用由链霉菌属或Amycolata属的微生物，特别是链霉菌属（Streptomyces sp。）产生的酶的相应的ML-236B化合物的酶促羟基化来制备。 SANK 62285，Streptomyces sp。 SANK 62385，Streptomyces sp。 SANK 62485，Streptomyces sp。 SANK 62585，Amycolata autotrophica SANK 62781，Amycolata autotrophica subsp。 canberrica SANK 62882或Amycolata autotrophica subsp。紫杉醇SANK 62981.这些衍生物具有抑制胆固醇生物合成的能力。

4. 发明授权

US5839567A Conveying system 失效
标题翻译：输送系统
公开(公告)号：US5839567A
公开(公告)日：1998-11-24
申请号：US584319
申请日：1996-01-16
申请人： Hisashi Kyotani , Takashi Okamura , Kiyoshi Hamano
发明人： Hisashi Kyotani , Takashi Okamura , Kiyoshi Hamano
IPC分类号： B61B10/02 , B61B13/12 , B62D65/18 , B65G35/06 , B65G17/32
CPC分类号： B61B13/127 , B61B10/025 , B62D65/18 , B65G35/06
摘要： The present invention relates to a conveying system such as in an assembly line, more particularly to a plurality of transport cars without motor that are driven in close contact with each other on an endless path on guide rails having curved sections, and a friction feeder for moving the transport cars. The cars have a main body and a support for objects to be conveyed. The main body has a plurality of movable bodies and means for coupling the movable bodies to allow a relative yielding motion between the movable bodies at the curved sections in the conveying paths. Driven faces are formed on the movable bodies parallel to the running direction, and a feeder along the conveying path and having a motor driven feed roller that acts on the driven faces of the movable bodies.
摘要翻译：本发明涉及一种诸如装配线的输送系统，更具体地说，涉及在具有弯曲部分的导轨上的循环路径上彼此紧密接触的多个无马达的运输车辆，以及用于移动运输车。汽车具有主体和支撑物体被输送。主体具有多个可移动体和用于联接可移动体以允许可移动体在输送路径中的弯曲部分处的相对屈服运动的装置。驱动面形成在平行于运行方向的可移动体上，沿着传送路径形成有进给器，并且具有作用在可移动体的从动面上的马达驱动进给辊。

5. 发明授权

US5272174A Hydroxy-ML-236B derivatives, their preparation and use 失效
标题翻译： Hydroxy-ML-236B衍生物，其制备和用途
公开(公告)号：US5272174A
公开(公告)日：1993-12-21
申请号：US919154
申请日：1992-07-23
申请人： Kouhei Furuya , Takao Okazaki , Yoshio Tsujita , Seigo Iwado , Kiyoshi Hamano , Masao Kuroda , Jun Yoshikawa , Toshiaki Iwai , Kunio Nakano
发明人： Kouhei Furuya , Takao Okazaki , Yoshio Tsujita , Seigo Iwado , Kiyoshi Hamano , Masao Kuroda , Jun Yoshikawa , Toshiaki Iwai , Kunio Nakano
IPC分类号： C07D309/10 , C12P7/62 , C12P17/06 , A61K31/365 , A61K31/215
CPC分类号： C12R1/645 , C07D309/10 , C12P17/06 , C12P7/62 , C12R1/365 , Y10S514/824
摘要： Derivatives of ML-236B carboxylic acid, its salts and esters and corresponding lactone have a hydroxy group at the 3"-position and optionally also at the 6'-position. These derivatives may be prepared by the enzymatic hydroxylation of a corresponding ML-236B compound employing an enzyme produced by a microorganism of the genus Streptomyces or Amycolata, especially Streptomyces sp. SANK 62285, Streptomyces sp. SANK 62385, Streptomyces sp. SANK 62485, Streptomyces sp. SANK 62585, Amycolata autotrophica SANK 62781. Amycolata autotrophica subsp. canberrica SANK 62882 or Amycolata autotrophica subsp. amethystina SANK 62981. These derivatives have the ability to inhibit cholesterol biosynthesis.
摘要翻译： ML-236B羧酸的衍生物，其盐和酯和相应的内酯在3“位和任选也在6'位具有羟基。这些衍生物可以通过使用由链霉菌属或Amycolata属的微生物，特别是链霉菌属（Streptomyces sp。）产生的酶的相应的ML-236B化合物的酶促羟基化来制备。 SANK 62285，Streptomyces sp。 SANK 62385，Streptomyces sp。 SANK 62485，Streptomyces sp。 SANK 62585，Amycolata autotrophica SANK 62781. Amycolata autotrophica subsp。 canberrica SANK 62882或Amycolata autotrophica subsp。紫杉醇SANK 62981.这些衍生物具有抑制胆固醇生物合成的能力。

6. 发明授权

US4361515A Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use 失效
标题翻译：抗高血脂二氢-ML-236B衍生物，其制备和用途
公开(公告)号：US4361515A
公开(公告)日：1982-11-30
申请号：US256243
申请日：1981-04-21
申请人： Akira Terahara , Kiyoshi Hamano , Yoshio Tsujita , Minoru Tanaka
发明人： Akira Terahara , Kiyoshi Hamano , Yoshio Tsujita , Minoru Tanaka
IPC分类号： C07C69/013 , A61K31/19 , A61K31/215 , A61K31/365 , A61K31/366 , A61P3/06 , C07C51/00 , C07C59/11 , C07C59/13 , C07C59/215 , C07C59/46 , C07C59/62 , C07C59/76 , C07C59/84 , C07C59/90 , C07C67/00 , C07C69/18 , C07C69/21 , C07C69/30 , C07C69/33 , C07C69/67 , C07C69/675 , C07C69/716 , C07C69/73 , C07C69/732 , C07C69/738 , C07C407/00 , C07C409/14 , C07D309/30
CPC分类号： C07D309/30 , C07C59/11 , C07C59/46 , C07C59/76 , C07C59/84
摘要： Compounds of formula (I): ##STR1## (in which: Z represents a group of formula ##STR2## A represents a group of formula ##STR3## B represents a group of formula ##STR4## R.sup.1 represents a hydrogen atom or a methyl group; R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are the same or different and each represents a hydrogen atom or an acyl group;R.sup.5 represents a carboxy group;R.sup.7 represents a hydrogen atom, an alkyl group or an acyl group;X represents a halogen atom; andthe bond represents a double bond)and salts and esters of the carboxy group represented by R.sup.5 and compounds of formula (II): ##STR5## (in which R.sup.1, is as defined above and R.sup.2 represents an .alpha.-methylbutyryl group; and R.sup.4 represents a hydrogen atom) have useful anti-hypercholesteraemic activity and may be prepared from certain natural products obtainable by cultivation of microorganisms of the genera Penicillium or Monascus.
摘要翻译：式（I）的化合物：其中：Z表示式的基团A表示式的基团：B表示式的基团R 1表示氢原子或甲基; R2，R3，R4和R6相同或不同，各自表示氢原子或酰基; R5表示羧基; R7表示氢原子，烷基或酰基; X表示卤素原子;键表示双键）和由R5表示的羧基和式（II）化合物的盐和酯：其中R 1如上所定义，R 2表示α - 甲基丁酰基; R4表示氢原子）具有有效的抗高胆固醇血症活性，并且可以通过培养青霉属或红曲霉属的微生物获得的某些天然产物制备。

7. 发明授权

US07939081B2 Method for producing cercosporamide 失效
标题翻译：铈孢子胺的制备方法
公开(公告)号：US07939081B2
公开(公告)日：2011-05-10
申请号：US11997112
申请日：2006-08-08
申请人： Tsuyoshi Hosoya , Jun Ohsumi , Kiyoshi Hamano , Yasunori Ono , Masami Miura
发明人： Tsuyoshi Hosoya , Jun Ohsumi , Kiyoshi Hamano , Yasunori Ono , Masami Miura
IPC分类号： A61K36/84 , C12P21/04 , A01N63/04
CPC分类号： C07D307/91 , C12P17/04 , C12R1/645
摘要： The present invention provides a process for producing cercosporamide comprising culturing a fungus belonging to the genus Lachnum and/or fungus belonging to the genus Pseudaegerita and recovering cercosporamide from the culture thereof. In addition, the present invention provides cercosporamide acquired according to this production process. Further, the present invention provides novel microorganisms consisting of Lachnum fuscescens SANK 19096, Lachnum calycioides SANK 12497, Lachnum caesaliatum SANK 10906, and Pseudaegerita websteri SANK 11006.
摘要翻译：本发明提供了一种生产铈孢子酰胺的方法，其包括培养属于属于假单胞菌属的Lachnum属和/或真菌的真菌并从其培养物中回收孢子虫酰胺。此外，本发明提供根据该制造方法获得的孢霉素。此外，本发明提供了由Lachnum fuscescens SANK 19096，Lachnum calycioides SANK 12497，Lachnum caesaliatum SANK 10906和Pseudaegerita websterica SANK 11006组成的新型微生物。

8. 发明授权

US4438277A Hydronaphthalene derivatives 失效
标题翻译：氢萘衍生物
公开(公告)号：US4438277A
公开(公告)日：1984-03-20
申请号：US368673
申请日：1982-04-15
申请人： Akira Terahara , Kiyoshi Hamano , Yoshio Tsujita , Minoru Tanaka
发明人： Akira Terahara , Kiyoshi Hamano , Yoshio Tsujita , Minoru Tanaka
IPC分类号： C07C69/013 , A61K31/19 , A61K31/215 , A61K31/365 , A61K31/366 , A61P3/06 , C07C51/00 , C07C59/11 , C07C59/13 , C07C59/215 , C07C59/46 , C07C59/62 , C07C59/76 , C07C59/84 , C07C59/90 , C07C67/00 , C07C69/18 , C07C69/21 , C07C69/30 , C07C69/33 , C07C69/67 , C07C69/675 , C07C69/716 , C07C69/73 , C07C69/732 , C07C69/738 , C07C407/00 , C07C409/14 , C07D309/30 , C07C69/03 , C07C69/734
CPC分类号： C07D309/30 , C07C59/11 , C07C59/46 , C07C59/76 , C07C59/84
摘要： Compounds of formula (I): ##STR1## (in which: Z represents a group of formula ##STR2## A represents a group of formula ##STR3## B represents a group of formula ##STR4## R.sup.1 represents a hydrogen atom or a methyl group; R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are the same or different and each represents a hydrogen atom or an acyl group;R.sup.5 represents a carboxy group;R.sup.7 represents a hydrogen atom, an alkyl group or an acyl group;X represents a halogen atom; andthe bond represents a double bond)and salts and esters of the carboxy group represented by R.sup.5 have useful anti-hypercholesteraemic activity and may be prepared from certain natural products obtainable by cultivation of microorganisms of the genera Penicillium or Monascus.
摘要翻译：式（I）的化合物：其中：Z表示式的基团A表示式的基团：B表示式的基团R 1表示氢原子或甲基; R2，R3，R4和R6相同或不同，各自表示氢原子或酰基; R5表示羧基; R7表示氢原子，烷基或酰基; X表示卤素原子;键表示双键），由R5表示的羧基的盐和酯具有有效的抗高胆固醇血症活性，并且可以由通过培养青霉属或红曲霉属的微生物获得的某些天然产物制备。

9. 发明申请

US20100152467A1 METHOD FOR PRODUCING CERCOSPORAMIDE 失效
标题翻译：生产羧甲基纤维素的方法
公开(公告)号：US20100152467A1
公开(公告)日：2010-06-17
申请号：US11997112
申请日：2006-08-08
申请人： Tsuyoshi Hosoya , Jun Ohsumi , Kiyoshi Hamano , Yasunori Ono , Masami Miura
发明人： Tsuyoshi Hosoya , Jun Ohsumi , Kiyoshi Hamano , Yasunori Ono , Masami Miura
IPC分类号： C07D307/77 , C12P17/04 , C12N1/14
CPC分类号： C07D307/91 , C12P17/04 , C12R1/645
摘要： The present invention provides a process for producing cercosporamide comprising culturing a fungus belonging to the genus Lachnum and/or fungus belonging to the genus Pseudaegerita and recovering cercosporamide from the culture thereof. In addition, the present invention provides cercosporamide acquired according to this production process. Further, the present invention provides novel microorganisms consisting of Lachnum fuscescens SANK 19096, Lachnum calycioides SANK 12497, Lachnum caesaliatum SANK 10906, and Pseudaegerita websteri SANK 11006.
摘要翻译：本发明提供了一种生产铈孢子酰胺的方法，其包括培养属于属于假单胞菌属的Lachnum属和/或真菌的真菌并从其培养物中回收孢子虫酰胺。此外，本发明提供根据该制造方法获得的孢霉素。此外，本发明提供了由Lachnum fuscescens SANK 19096，Lachnum calycioides SANK 12497，Lachnum caesaliatum SANK 10906和Pseudaegerita websterica SANK 11006组成的新型微生物。

10. 发明授权

US5260447A Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use 失效
标题翻译：多羟基环戊烷衍生物，其制备及其治疗用途
公开(公告)号：US5260447A
公开(公告)日：1993-11-09
申请号：US835185
申请日：1992-02-13
申请人： Mutsuo Nakajima , Osamu Ando , Kiyoshi Hamano , Shuji Takahashi , Takeshi Kinoshita , Hideyuki Haruyama , Akira Sato , Yasuyuki Takamatsu , Ryuzo Enokita
发明人： Mutsuo Nakajima , Osamu Ando , Kiyoshi Hamano , Shuji Takahashi , Takeshi Kinoshita , Hideyuki Haruyama , Akira Sato , Yasuyuki Takamatsu , Ryuzo Enokita
IPC分类号： C07C215/42 , A61K20060101 , A61K31/13 , C07C20060101 , C07C215/44 , C07D263/52 , C07D413/12 , C12P7/38 , C12P17/14 , C07D261/20 , C07C211/00
CPC分类号： C07D263/52 , C07C215/44 , C07D413/10 , C12P17/14 , C07C2101/06
摘要： 5-Amino-1-(hydroxymethyl)cyclopentane-1,2,3,4-tetraol and 2-amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole-4,5,6-triol, which have the ability to inhibit the activity of sugar hydrolases, especially .beta.-glucosidase and sucrase and can thus be used for the treatment and prophylaxis of tumorous conditions, AIDS, diabetes and obesity, can be prepared by hydrolysis of trehazolin. 2-Amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole-4,5,6-triol can also be prepared by fermentation using newly isolated strains Micromonospora sp. SANK 62390, FERM BP-3521 and Amycolatopsis sp. SANK 60791, FERM BP-3513.
摘要翻译： 5-氨基-1-（羟甲基）环戊烷-1,2,3,4-四醇和2-氨基-4-（羟甲基）-3a，5,6,6a-四氢-4H-环戊二烯并[d]恶唑-4 具有抑制糖水解酶，特别是β-葡糖苷酶和蔗糖酶的活性，因此可用于治疗和预防肿瘤病症，AIDS，糖尿病和肥胖症的能力的5,6-三醇可以通过水解制备的trehazolin。 2-氨基-4-（羟甲基）-3a，5,6,6a-四氢-4H-环戊[d]恶唑-4,5,6-三醇也可以通过使用新分离的小单孢菌属 SANK 62390，FERM BP-3521和Amycolatopsis sp。 SANK 60791，FERM BP-3513。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式